Brunello Cucinelli Family to Support Scientific Project
Brunello Cucinelli and his family are supporting the research to develop innovative drugs for the treatment of metabolic and oncological diseases.
Source: wwd.com
Mark Pruzanski News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mark Pruzanski. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mark Pruzanski Today - Breaking & Trending Today
Lilly to Acquire Versanis to Improve Patient Outcomes in Cardiometabolic Diseases
Eli Lilly and Company (NYSE: LLY) and Versanis Bio today announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of cardiometabolic diseases. Versanis' lead asset is bimagrumab, a monoclonal ...
Source: pharmiweb.com
Eli Lilly agrees to buy weight-loss drugmaker Versanis for nearly $2 billion
Eli Lilly announced Friday a $1.93 billion cash deal to buy Versanis, a private clinical-stage biopharmaceutical company focused on weight-loss drugs.
Source: upi.com
Lilly to Acquire Versanis to Improve Patient Outcomes in Cardiometabolic Diseases
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Versanis Bio today announced a definitive agreement for Lilly to acquire Versanis, a private...
Source: prnewswire.com
Eli Lilly agrees to buy weight-loss drugmaker Versanis for nearly $2 billion
Eli Lilly announced Friday a $1.93 billion cash deal to buy Versanis, a private clinical-stage biopharmaceutical company focused on weight-loss drugs.
Source: upi.com